September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
The Association of Apolipoprotein E and Membrane Attack Complex in Human RPE Cell
Author Affiliations & Notes
  • Ping Yang
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Victoria Treboschi
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Peter Baciu
    Biology, Allergan, Inc, Irvine, California, United States
  • Glenn J Jaffe
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Ping Yang, None; Victoria Treboschi, None; Peter Baciu, Allergan, Inc (E); Glenn Jaffe, None
  • Footnotes
    Support  NIH 5P30EY005722 (Core grant) and Research to Prevent Blindness.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6531. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ping Yang, Victoria Treboschi, Peter Baciu, Glenn J Jaffe; The Association of Apolipoprotein E and Membrane Attack Complex in Human RPE Cell. Invest. Ophthalmol. Vis. Sci. 2016;57(12):6531.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Complement activation has been increasingly implicated in the pathogenesis of AMD. Apolipoprotein E (ApoE) and complement activation products such as membrane attack complex (MAC) have been detected in Bruch’s membrane (BrM) and drusen from eyes with AMD. We previously reported complement activation induced time-dependent ApoE accumulation in human RPE cells. Herein, we test the hypothesis that the interaction between ApoE and MAC contribute to increased cell-associated ApoE. We also evaluated the relationship between complement activation and ApoE expression in human eyes and mouse models.

Methods : Cultured human RPE cells were primed with a complement-fixing antibody and then treated with either 6% C1q-depleted human serum (C1q-Dep) to elicit cell surface MAC formation or heat inactivated C1q-Dep to block complement activation. Repetitive complement attack was induced every other day for 1 week (three attacks). RPE cells were incubated for 15 minutes with 0.02N ammonium hydroxide 48 hrs after the third complement attack. Western blot was performed on RPE cell-conditioned media, total cellular lysate proteins and extracellular matrix (ECM). ApoE and MAC co-localization were assessed on cultured human RPE cells and human eyes. C3d and ApoE were examined by immunofluorescent microscopy in ApoB 100 transgenic mice and CD55/CD59 double deficient (KO) mice.

Results : After a single complement attack, when compared to controls, decreased cell-associated ApoE was accompanied by increased release of ApoE into conditioned media at days 1, 2 and 3 post complement challenge. Cell-associated S58 priming antibody was decreased on RPE cells in a pattern similar to that observed with ApoE protein. ApoE and MAC were frequently co-localized in complement-treated cells, but not in control cells. ApoE was co-distributed with MAC in sub-RPE deposits and drusen from human eyes. Repeated complement attack dramatically enhanced RPE ApoE accumulation and caused ApoE ECM deposition. C3d and ApoE were detected in BrM of ApoB 100 transgenic mice as well as CD55/CD59 KO mice.

Conclusions : Complement-mediated RPE cell-associated ApoE accumulation and subsequent release may be one of mechanisms that accounts for ApoE in drusen. This information will enhance our understanding of the role that complement activation plays to mediate drusen formation and composition, and may elucidate potential therapeutic targets.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×